Eastman Chemical (EMN) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts EMN Hot Sheet
Price: $72.44 --0%
EPS Growth %: +71.9%
Financial Fact:
Retained earnings at end of period: 5.68B
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +71.9%
Financial Fact:
Retained earnings at end of period: 5.68B
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.46, $0.02 worse than the analyst estimate of $2.48. Revenue for the quarter came in at $2.72 billion versus the consensus estimate of $2.61 billion.
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Profound Medical names Richard Fabian as president
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
